Internal Reference Number: FOI_7546
Date Request Received: 10/11/2023 00:00:00
Date Request Replied To: 20/11/2023 00:00:00
This response was sent via: By Email
Request Summary: MRI scans
Request Category: Companies
| Question Number 1: Please provide the above information for the five financial years ending 2021/22. The number of MRI scans performed for the following, Central Nervous System 鈥� Brain 鈥� Spine 鈥� Other Surrounding Tissue 鈥� Whole Body 鈥� Head & Neck 鈥� Thorax, including Breast 鈥� Abdomen, including Liver & Kidneys 鈥� Pelvis, including Prostate 鈥� Musculo-skeletal system 鈥� Other 鈥� Cardiac 鈥� Angiography | |
| Answer To Question 1: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. To accompany this answer to question 1 please also see the documents listed below:  11810 - FOI_7546 - MRI Scans For issue.xlsx | |
| Question Number 2: The number of MRI scans for the above listed investigations using a macrocyclic gadolinium contrast agent(s) | |
| Answer To Question 2: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
| Question Number 3: The average number of doses of a macrocyclic gadolinium contrast agent(s) per scan | |
| Answer To Question 3: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
| Question Number 4: The number of rescans, which are performed due to the outcome of a poor-quality image when using a macrocyclic gadolinium contrast agent in the initial scan. | |
| Answer To Question 4: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
| Question Number 5: The number of rereports required due to the outcome of a poor-quality image when using a macrocyclic gadolinium contrast agent in the initial scan. | |
| Answer To Question 5: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 看片软件 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
